BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3569474)

  • 1. Fasciola hepatica: liver enzymes in rats and interaction with chemical inducers.
    Galtier P; Eeckhoutte C; Larrieu G
    Exp Parasitol; 1987 Apr; 63(2):189-94. PubMed ID: 3569474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential inhibition of rat hepatic glutathione S-transferase isoenzymes in the course of fascioliasis.
    Galtier P; Vandenberghe Y; Coecke S; Eeckhoutte C; Larrieu G; Vercruysse A
    Mol Biochem Parasitol; 1991 Feb; 44(2):255-60. PubMed ID: 2052025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of hepatic and renal drug-metabolising enzyme activities in sheep given single or two-fold challenge infections with Fasciola hepatica.
    Calléja C; Bigot K; Eeckhoutte C; Sibille P; Boulard C; Galtier P
    Int J Parasitol; 2000 Jul; 30(8):953-8. PubMed ID: 10927086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of experimental fascioliasis on the activity of drug-metabolizing enzymes in lamb liver.
    Galtier P; Larrieu G; Tufenkji AE; Franc M
    Drug Metab Dispos; 1986; 14(1):137-41. PubMed ID: 2868858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of drug metabolizing enzymes in the liver of rats infested with Fasciola hepatica.
    Galtier P; Larrieu G; Lesca P
    J Pharm Pharmacol; 1985 Oct; 37(10):751-4. PubMed ID: 2867151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fasciola hepatica: liver microsomal membrane functions in host rat.
    Galtier P; Cambon-Gros C; Fernandez Y; Deltour P; Eeckhoutte C; Hoellinger H
    Exp Parasitol; 1994 Mar; 78(2):175-82. PubMed ID: 7907029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of substrate binding capacity of the hepatic microsomal cytochrome P-450 in Fasciola hepatica infected rats: toxicological implications.
    Maffei Facino R; Carini M
    Farmaco Sci; 1982 Mar; 37(3):184-91. PubMed ID: 6802668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of hepatic and extrahepatic drug-metabolizing enzyme activities in rats given single or multiple challenge infections with Fasciola hepatica.
    Biro-Sauveur B; Eeckhoutte C; Baeza E; Boulard C; Galtier P
    Int J Parasitol; 1995 Oct; 25(10):1193-200. PubMed ID: 8557466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xenobiotic metabolizing enzymes are not restricted to parenchymal cells in rat liver.
    Steinberg P; Lafranconi WM; Wolf CR; Waxman DJ; Oesch F; Friedberg T
    Mol Pharmacol; 1987 Oct; 32(4):463-70. PubMed ID: 3670281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihepatotoxic properties of uridine-diphosphoglucose in liver fluke infection. Experimental fascioliasis in the rat.
    Maffei Facino R; Carini M; Genchi C; Tofanetti O; Casciarri I; Bedoschi D
    Arzneimittelforschung; 1990 Apr; 40(4):490-8. PubMed ID: 2113387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of microsomal enzyme inducing agents on hepatic biotransformation in cotton rats (Sigmodon hispidus): comparison to that in Sprague-Dawley rats.
    Watkins JB
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1991; 98(2-3):433-9. PubMed ID: 1676957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of cytosolic glutathione transferase and microsomal epoxide hydrolase activities in extrahepatic organs of the rat by phenobarbital, 3-methylcholanthrene and trans-stilbene oxide.
    DePierre JW; Seidegård J; Morgenstern R; Balk L; Meijer J; Aström A; Norélius I; Ernster L
    Xenobiotica; 1984 Apr; 14(4):295-301. PubMed ID: 6464499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in inducibility of particulate and cytosolic rat liver glutathione S-transferase activities.
    Mukhtar H; Baars AJ; Breimer DD
    Xenobiotica; 1981 Jun; 11(6):367-71. PubMed ID: 7293227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutathione S-transferase activity in rat pancreas.
    Black O; Howerton BK
    J Natl Cancer Inst; 1984 Jan; 72(1):121-3. PubMed ID: 6582291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of drug metabolism by the liver in experimental fascioliasis in the rat.
    Galtier P; Battaglia A; More J; Franc M
    J Pharm Pharmacol; 1983 Nov; 35(11):729-33. PubMed ID: 6139454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activities of drug-metabolizing enzymes in the liver of Suncus murinus: possible lack of N-acetyltransferase activity in liver cytosol.
    Nakura H; Itoh S; Kusano H; Ishizone H; Kamataki T
    Pharmacology; 1994 Mar; 48(3):201-4. PubMed ID: 8153148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstration of functional heterogeneity of hepatic uridine diphosphate glucuronosyltransferase activities after administration of 3-methylcholanthrene and phenobarbital to rats.
    Wishart GJ
    Biochem J; 1978 Aug; 174(2):671-2. PubMed ID: 101214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of phenobarbital and sodium salicylate on cytochrome P-450 mixed function oxygenase and glutathione S-transferase activities in rat brain.
    Chand P; Clausen J
    Chem Biol Interact; 1982 Jul; 40(3):357-63. PubMed ID: 7083399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered induction response of hepatic cytochrome P-450 to phenobarbital, 3-methylcholanthrene, and beta-naphthoflavone in organotin-treated animals.
    Rosenberg DW; Sardana MK; Kappas A
    Biochem Pharmacol; 1985 Apr; 34(7):997-1005. PubMed ID: 3986002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in liver microsomal glutathione S-transferase activity by phenobarbital treatment of rats. Possible involvement of oxidative activation via cytochrome P450.
    Aniya Y; Shimoji M; Naito A
    Biochem Pharmacol; 1993 Nov; 46(10):1741-7. PubMed ID: 8250959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.